{"DataElement":{"publicId":"14429704","version":"1","preferredName":"Person Lymphoma MYC And BCL2 Gene Rearrangement And/Or BCL6 Gene Rearrangement Indicator","preferredDefinition":"Indicator of whether a person's lymphoma is MYC and BCL2 gene rearrangement and/or BCL5 gene rearrangement(s).","longName":"14429575v1.00:14429700v1.00","context":"AMC","contextVersion":"1","DataElementConcept":{"publicId":"14429575","version":"1","preferredName":"Lymphoma MYC Gene Rearrangement And BCL2 Gene Rearrangement And Or BCL6 Gene Rearrangement","preferredDefinition":"A malignant (clonal) proliferation of B- lymphocytes or T- lymphocytes which involves the lymph nodes, bone marrow and/or extranodal sites. This category includes Non-Hodgkin lymphomas and Hodgkin lymphomas.:A molecular abnormality indicating rearrangement of the MYC gene._An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence._A molecular abnormality indicating rearrangement of the BCL2 gene._An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._A molecular abnormality indicating rearrangement of the BCL6 gene.","longName":"2475110v1.00:14434096v1.00","context":"AMC","contextVersion":"1","ObjectClass":{"publicId":"2475110","version":"1","preferredName":"Lymphoma","preferredDefinition":"A malignant (clonal) proliferation of B- or T- lymphocytes which involves the lymph nodes, bone marrow and/or extranodal sites.  This category includes Non-Hodgkin's lymphomas and Hodgkin's lymphomas. -- 2003","longName":"C3208","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lymphoma","conceptCode":"C3208","definition":"A malignant (clonal) proliferation of B- lymphocytes or T- lymphocytes which involves the lymph nodes, bone marrow and/or extranodal sites. This category includes Non-Hodgkin lymphomas and Hodgkin lymphomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"11901624-1EB2-3055-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-16","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-04-16","modifiedBy":"ONEDATA","dateModified":"2006-04-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"14434096","version":"1","preferredName":"MYC Gene Rearrangement And BCL2 Gene Rearrangement And Or BCL6 Gene Rearrangement","preferredDefinition":"A molecular abnormality indicating rearrangement of the MYC gene._An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence._A molecular abnormality indicating rearrangement of the BCL2 gene._An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._A molecular abnormality indicating rearrangement of the BCL6 gene.","longName":"14434096v1.00","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"MYC Gene Rearrangement","conceptCode":"C132018","definition":"A molecular abnormality indicating rearrangement of the MYC gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"5"},{"longName":"And","conceptCode":"C37912","definition":"An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"BCL2 Gene Rearrangement","conceptCode":"C132019","definition":"A molecular abnormality indicating rearrangement of the BCL2 gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"And","conceptCode":"C37912","definition":"An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"BCL6 Gene Rearrangement","conceptCode":"C132020","definition":"A molecular abnormality indicating rearrangement of the BCL6 gene.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"03FFCBE0-9E7D-53C1-E063-731AD00A6DC0","latestVersionIndicator":"Yes","beginDate":"2023-08-28","endDate":null,"createdBy":"TSESU","dateCreated":"2023-08-28","modifiedBy":"TSESU","dateModified":"2023-08-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"03AFDB9F-5DB0-1151-E063-731AD00AF79C","latestVersionIndicator":"Yes","beginDate":"2023-08-24","endDate":null,"createdBy":"TSESU","dateCreated":"2023-08-24","modifiedBy":"TSESU","dateModified":"2024-01-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"14429700","version":"1","preferredName":"Indicator","preferredDefinition":"An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.","longName":"14429700v1.00","context":"AMC","contextVersion":"1","type":"Enumerated","dataType":"NUMBER","minLength":null,"maxLength":null,"minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"1","valueDescription":null,"ValueMeaning":{"publicId":"14429701","version":"1","preferredName":"Yes, double-hit lymphoma (MYC and BCL2)","longName":"14429701v1.00","preferredDefinition":"Yes, double-hit lymphoma (MYC and BCL2)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"03CAE4BD-24DC-55D4-E063-731AD00A60F2","latestVersionIndicator":"Yes","beginDate":"2023-08-25","endDate":null,"createdBy":"TSESU","dateCreated":"2023-08-25","modifiedBy":"TSESU","dateModified":"2023-08-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"03CAE4BD-24DF-55D4-E063-731AD00A60F2","beginDate":"2023-08-25","endDate":null,"createdBy":"TSESU","dateCreated":"2023-08-25","modifiedBy":"TSESU","dateModified":"2023-08-25","deletedIndicator":"No"},{"value":"2","valueDescription":null,"ValueMeaning":{"publicId":"14429702","version":"1","preferredName":"Yes, double-hit lymphoma (MYC and BCL6)","longName":"14429702v1.00","preferredDefinition":"Yes, double-hit lymphoma (MYC and BCL6)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"03CAE4BD-24DD-55D4-E063-731AD00A60F2","latestVersionIndicator":"Yes","beginDate":"2023-08-25","endDate":null,"createdBy":"TSESU","dateCreated":"2023-08-25","modifiedBy":"TSESU","dateModified":"2023-08-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"03CAE4BD-24E0-55D4-E063-731AD00A60F2","beginDate":"2023-08-25","endDate":null,"createdBy":"TSESU","dateCreated":"2023-08-25","modifiedBy":"TSESU","dateModified":"2023-08-25","deletedIndicator":"No"},{"value":"3","valueDescription":null,"ValueMeaning":{"publicId":"14429703","version":"1","preferredName":"Yes, triple-hit lymphoma","longName":"14429703v1.00","preferredDefinition":"Yes, triple-hit lymphoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"03CAE4BD-24DE-55D4-E063-731AD00A60F2","latestVersionIndicator":"Yes","beginDate":"2023-08-25","endDate":null,"createdBy":"TSESU","dateCreated":"2023-08-25","modifiedBy":"TSESU","dateModified":"2023-08-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"03CAE4BD-24E1-55D4-E063-731AD00A60F2","beginDate":"2023-08-25","endDate":null,"createdBy":"TSESU","dateCreated":"2023-08-25","modifiedBy":"TSESU","dateModified":"2023-08-25","deletedIndicator":"No"},{"value":"4","valueDescription":null,"ValueMeaning":{"publicId":"5697866","version":"1","preferredName":"No","longName":"5697866","preferredDefinition":"The non-affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A23568A-7775-5975-E053-F662850A8E6C","latestVersionIndicator":"Yes","beginDate":"2017-03-07","endDate":null,"createdBy":"ALEYR","dateCreated":"2017-03-07","modifiedBy":"KUMMEROA","dateModified":"2023-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"03CAE4BD-24E2-55D4-E063-731AD00A60F2","beginDate":"2023-08-25","endDate":null,"createdBy":"TSESU","dateCreated":"2023-08-25","modifiedBy":"TSESU","dateModified":"2023-08-25","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2320047","version":"1","preferredName":"Indicator","preferredDefinition":"An event, entity or condition that typically characterizes a prescribed environment or situation. Indicators determine or aid in determining whether or not certain stated circumstances exist or criteria are satisfied. (On-line Medical Dictionary)","longName":"C25180","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Indicator","conceptCode":"C25180","definition":"An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"FC6EF0D8-521A-6865-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-07-25","modifiedBy":"ONEDATA","dateModified":"2005-07-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"03CAD79A-0EDA-53F6-E063-731AD00A2312","latestVersionIndicator":"Yes","beginDate":"2023-08-25","endDate":null,"createdBy":"TSESU","dateCreated":"2023-08-25","modifiedBy":"TSESU","dateModified":"2023-08-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"LYMPHOMA_CAT","type":"OID, AMC","context":"AMC"}],"ReferenceDocuments":[{"name":"PQT","type":"Preferred Question Text","description":"Is the participant's lymphoma categorized as double-hit or triple-hit lymphoma (rearrangement of MYC and BCL2 and/or BCL6 genes)?","url":null,"context":"AMC"}],"origin":null,"workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"03CAF3E9-99C4-605C-E063-731AD00A9215","latestVersionIndicator":"Yes","beginDate":"2023-08-25","endDate":null,"createdBy":"TSESU","dateCreated":"2023-08-25","modifiedBy":"TSESU","dateModified":"2023-08-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}